Search

Author/Creator Gielen, Ellis

1. 704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models. (9th November 2020)

Authors:
Kemper, Kristel; Gielen, Ellis; Houtkamp, Mischa; Boross, Peter; Burm, Saskia; Poot, Stefanie De; Engelberts, Patrick; Goeij, Bart de; Satijn, David; Sasser, Kate; Breij, Esther
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A746
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models. (9th November 2020)

Authors:
Kemper, Kristel; Gielen, Ellis; Houtkamp, Mischa; Boross, Peter; Burm, Saskia; Poot, Stefanie De; Engelberts, Patrick; Goeij, Bart de; Satijn, David; Sasser, Kate; Breij, Esther
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A423
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. CXCR4, but not CXCR3, drives CD8+ T‐cell entry into and migration through the murine bone marrow. Issue 4 (15th February 2019)

Authors:
Goedhart, Marieke; Gessel, Stephanie; van der Voort, Robbert; Slot, Edith; Lucas, Beth; Gielen, Ellis; Hoogenboezem, Mark; Rademakers, Timo; Geerman, Sulima; van Buul, Jaap D.; Huveneers, Stephan; Dolstra, Harry; Anderson, Graham; Voermans, Carlijn; Nolte, Martijn A.
Journal:
European journal of immunology
Issue:
Volume 49:Issue 4(2019)
Page Start:
576
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗